HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Günter Auerswald Selected Research

Hemophilia A (Haemophilia)

5/2021Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel.
5/2021Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors.
10/2017Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment.
1/2017Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors.
12/2016Pain and pain management in haemophilia.
12/2015Rationale for individualizing haemophilia care.
4/2015Switching treatments in haemophilia: is there a risk of inhibitor development?
11/2014Prospective study of continuous infusion with Beriate® P in patients with severe haemophilia A undergoing surgery - a subgroup analysis.
6/2014Joint disease, the hallmark of haemophilia: what issues and challenges remain despite the development of effective therapies?
5/2013Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Günter Auerswald Research Topics

Disease

15Hemophilia A (Haemophilia)
05/2021 - 06/2003
6Hemorrhage
05/2021 - 05/2008
3von Willebrand Diseases (von Willebrand's Disease)
01/2024 - 04/2002
3Factor VII Deficiency (Hypoproconvertinemia)
02/2013 - 03/2005
2Metrorrhagia (Spotting)
05/2021 - 05/2021
2Thrombosis (Thrombus)
05/2021 - 02/2013
2Joint Diseases (Joint Disease)
01/2017 - 06/2014
2Body Weight (Weight, Body)
02/2011 - 05/2009
1Thrombotic Microangiopathies
05/2021
1Chronic Pain
12/2016
1Pain (Aches)
12/2016
1Arthralgia (Joint Pain)
12/2016
1Menorrhagia
02/2013
1Epistaxis (Nosebleed)
02/2013

Drug/Important Bio-Agent (IBA)

8Factor VIII (Coagulation Factor VIII)IBA
01/2024 - 06/2007
4recombinant FVIIa (rFVIIa)FDA Link
01/2017 - 05/2009
3Factor VIIa (Activated Factor VII)IBA
05/2021 - 02/2011
3von Willebrand factor drug combination factor VIIIIBA
05/2008 - 04/2002
2von Willebrand FactorIBA
01/2024 - 05/2008
2emicizumabIBA
05/2021 - 05/2021
2Biomarkers (Surrogate Marker)IBA
01/2017 - 06/2014
1Prothrombin (Factor II)IBA
05/2021
1SteroidsIBA
12/2016
1N 30IBA
02/2013
1Blood Coagulation Factors (Coagulation Factor)IBA
07/2012
1Arginine Vasopressin (Argipressin)IBA
05/2008
1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
05/2008
1AntibodiesIBA
06/2007
1Factor VII (Proconvertin)IBA
03/2005

Therapy/Procedure

8Therapeutics
05/2021 - 02/2011
2Injections
12/2016 - 05/2009
1Pain Management
12/2016
1Operative Surgical Procedures
11/2014